Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Fewer than one half of all European patients following a heart attack are even receiving the benefits of cardiac rehabilitation and preventive care.
Sophia Antipolis, 17 February 2015. The large majority of coronary patients in Europe are failing to achieve their lifestyle, risk factor and therapeutic targets as set out in the latest prevention guidelines. Fewer than one half of all European patients following a heart attack are even receiving the benefits of cardiac rehabilitation and preventive care. In the light of the findings, from EUROASPIRE IV, largest survey of coronary care in Europe, the investigators are now calling for "a new approach to cardiovascular prevention . . . which integrates cardiac rehabilitation and secondary prevention into modern preventive cardiology programmes with appropriate adaptation to medical and cultural settings in each country". Such an approach, they add, requires multidisciplinary teams and should involve both patients and their families in a bid to achieve prevention targets and improve quality of life and survival.EUROASPIRE IV is an ongoing survey run under the auspices of the European Society of Cardiology EURObservational Research Programme.(1) This latest survey was undertaken at 78 centres in 24 European countries.(2) A total of 16,426 medical records were reviewed and 7998 coronary patients identified and interviewed. The median time between index event and interview was 1.35 years. The results of the survey are reported today in the European Journal of Preventive Cardiology.(3) Throughout the two decades of EUROASPIRE surveys, results have reflected continuing adverse lifestyle trends, in particular an evident increase in obesity and a persistently high prevalence of smoking in younger patients. This latest survey, performed throughout 2012 and 2013, shows emphatically that these trends continue. For example:
In reviewing the results the investigators note considerable variation between European countries in lifestyle and risk factor management, the use of cardioprotective medication, and the provision of rehabilitations services. Indeed, despite the strength of evidence, cardiac prevention and rehabilitation in Europe continues to be widely underused, they say, with enormous heterogeneity in service provision between countries. Overall less than one-half of coronary patients access such services.(4)The study's first author and Chair of the EUROASPIRE Steering Committee, Dr Kornelia Kotseva from the National Heart and Lung Institute, Imperial College London, described the results as "very disappointing".She said:
"A large majority of coronary patients do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets, physical inactivity and consequently most patients are overweight or obese with a high prevalence of diabetes. Risk factor control is inadequate despite high reported use of medications and there are large variations in secondary prevention practice between centres. Despite the existence of clear, evidence-based guidelines, their integration into routine clinical care remains disappointing, and there is still much room to raise the standards of preventive cardiology throughout Europe.”
EUROASPIRE's Principal Investigator, Professor David Wood, also from the National Heart and Lung Institute in London, added:
"Acute intervention should always be followed by prevention. While the cardiology community is focussed on rescuing the acutely ischaemic myocardium, there is insufficient investment in protecting the heart and circulation.”
1. The EUROASPIRE (European Action on Secondary and Primary Prevention by Intervention to Reduce Events) surveys, have evaluated guideline implementation since 1995–1996 in coronary patients (ie, secondary prevention). The main objectives of EUROASPIRE IV were to identify risk factors in patients with and without diabetes, describe their management through lifestyle and drug therapies and provide an objective assessment based on current scientific knowledge.2. Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic., Finland, France, Germany, Greece, Ireland, Latvia, Lithuania, the Netherlands, Poland, Romania, Russia, Serbia, Slovenia, Spain, Sweden, Turkey, Ukraine and the UK.3. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prevent Cardiol 2015: DOI: 10.1177/2047487315569401.4. Journalists looking for a local angle on this story can access the national data from this study in supplementary information available from the ESC press office.
© 2017 European Society of Cardiology. All rights reserved